TRICHLOROETHANE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 133.0 | 2.4 | 0 | 0 | 0.0 | 0 | 1.0 |
- CAS
- 71556
- UNII
- 113C650IR1
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 27 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02252146 | 2014-06-01 | Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88L265P Mutation | Phase 1/Phase 2 | Recruiting |
| NCT02130973 | 2013-08-01 | The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab | Phase 4 | Recruiting |
| NCT00855452 | 2009-01-01 | Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors | Phase 2 | Recruiting |